Project Grant HT94252410933

Award Date 9/1/24
Completion Date 8/31/25
Dollars Obligated $460K
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Orinda, CA 94563, USA
Similar Awards
The Department of the Army Medical Command awarded a $650,000 Project Grant under the Military Medical Research and Development (CFDA 12.420) federal grant program to The Trustees of Columbia University in the City of New York, Health Sciences Division. The award, titled "PSYCHIATRIC ASPECTS OF POST-TRAUMATIC EPILEPSY", will support advanced biomedical research focused on transforming healthcare for military service members and the broader public. The grant has a performance period...
The Department of the Army Medical Command awarded a $503,599 Project Grant to Massachusetts General Hospital through the Military Medical Research and Development program. The grant will fund research from June 1, 2022 to May 31, 2025 to exploit thalamocortical interactions for seizure termination in multifocal epilepsy. As part of the Military Medical Research and Development program's goal of transforming health care through innovative medical research, this award will support Massachusetts...
The Washington University received a $236,250 project grant award from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420). The grant funding supports research from July 1, 2021 to June 30, 2023 to study the role of blood-brain barrier dysfunction in epilepsy associated with tuberous sclerosis complex. The Military Medical Research and Development program aims to transform military and public health through innovative biomedical...
The Department of the Army Medical Command has awarded a $488,086 Project Grant under the Military Medical Research and Development (CFDA 12.420) program to The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc. The grant, effective from May 1, 2025 to April 30, 2027, will support advanced biomedical research on "Biomarker Signatures of Post-Traumatic Epileptogenesis (PTEGenesis) and Its Treatments." The Henry M. Jackson Foundation, a non-profit organization...
The Department of the Army Medical Command awarded Rutgers, The State University of New Jersey a $751,587 Project Grant under the Military Medical Research and Development program (CFDA 12.420). The grant will fund research targeting adenosine kinase for the prevention of post-traumatic epilepsy from September 30, 2022 to September 29, 2025. The Military Medical Research and Development program supports basic, applied, and advanced biomedical research to transform military and public health...
The Department of the Army Medical Command awarded a $2,008,900 project grant to the Veterans Medical Research Foundation of San Diego under the Military Medical Research and Development program (CFDA 12.420). The four-year project grant will fund research into combined nonpharmacological therapies for mild traumatic brain injury (mTBI)-related headaches from September 2021 through August 2025. The Military Medical Research and Development program supports basic, applied, and advanced biomedical...
The Department of the Army Medical Command awarded a $3,099,990 project grant to the Western Institute For Veterans Research under the Military Medical Research and Development program (CFDA 12.420). The grant will fund the MILITARY INJURIES - UNDERSTANDING POST-TRAUMATIC EPILEPSY (MINUTE): BIOINFORMATICS WITH BIG DATA TO EXAMINE MULTIMODAL PTE BIOMARKERS project from September 30, 2021 through September 29, 2025. The project aims to utilize bioinformatics and big data approaches to examine...
The Department of the Army Medical Command awarded $745,304 to Texas A&M University Health Science Center under the Military Medical Research and Development program (CFDA 12.420) to support the project "Epigenetic Therapy for Post-Traumatic Epilepsy" from September 30, 2022 through September 29, 2025. The project aims to develop innovative medical solutions for traumatic brain injury through basic, applied, and advanced biomedical research investigating epigenetic approaches to...
The Department of the Army Medical Command has awarded a $999,975.63 Project Grant under the Military Medical Research and Development (CFDA 12.420) program to the Icahn School of Medicine at Mount Sinai. The award, effective April 1, 2025 through March 31, 2028, will support research on the "Molecular Mechanisms of APOE4 Vulnerability to Alzheimer's Disease and Identification of Novel Therapeutic Targets." This grant aims to advance biomedical research that can transform healthcare...
The Department of the Army Medical Command awarded a $755,250 Project Grant to The Ohio State University Office of Sponsored Programs through the Military Medical Research and Development federal grant program. The three-year award beginning September 30, 2022 will fund research to define the genetic basis and pathologic network of post-traumatic epilepsy using Collaborative Cross mice. As part of the Military Medical Research and Development program's goals to transform military and public...

The Department of the Army Medical Command, through the Military Medical Research and Development (CFDA 12.420) federal grant program, awarded Encephalogix, Inc. a $459,994 Project Grant to support epilepsy research. The award, effective from Sep 1, 2024 to Aug 31, 2025, will fund the company's "Epilepsy Research Program Idea Development Award" to explore innovative approaches to the prevention, diagnosis, treatment, and management of epilepsy, a condition relevant to military personnel and veterans. The Military Medical Research and Development program, administered by the Defense Health Agency, focuses on transforming healthcare for Service Members and the general public through advanced biomedical research initiatives spanning basic, applied, and translational science across various medical disciplines.

Generated 5/13/25, 4:35 AM